Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study.
Breast cancer
Cancer survivors
Dietary patterns
Mediterranean diet
Prospective studies
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
26 06 2023
26 06 2023
Historique:
received:
03
04
2023
accepted:
08
06
2023
medline:
28
6
2023
pubmed:
27
6
2023
entrez:
26
6
2023
Statut:
epublish
Résumé
The Mediterranean diet has been associated with lower risk of breast cancer (BC) but evidence from prospective studies on the role of Mediterranean diet on BC survival remains sparse and conflicting. We aimed to investigate whether adherence to Mediterranean diet prior to diagnosis is associated with overall and BC-specific mortality. A total of 13,270 incident breast cancer cases were identified from an initial sample of 318,686 women in 9 countries from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Adherence to Mediterranean diet was estimated through the adapted relative Mediterranean diet (arMED), a 16-point score that includes 8 key components of the Mediterranean diet and excludes alcohol. The degree of adherence to arMED was classified as low (score 0-5), medium (score 6-8), and high (score 9-16). Multivariable Cox proportional hazards models were used to analyze the association between the arMED score and overall mortality, and Fine-Gray competing risks models were applied for BC-specific mortality. After a mean follow-up of 8.6 years from diagnosis, 2340 women died, including 1475 from breast cancer. Among all BC survivors, low compared to medium adherence to arMED score was associated with a 13% higher risk of all-cause mortality (HR 1.13, 95%CI 1.01-1.26). High compared to medium adherence to arMED showed a non-statistically significant association (HR 0.94; 95% CI 0.84-1.05). With no statistically significant departures from linearity, on a continuous scale, a 3-unit increase in the arMED score was associated with an 8% reduced risk of overall mortality (HR Consuming a Mediterranean diet before BC diagnosis may improve long-term prognosis, particularly after menopause and in cases of metastatic breast cancer. Well-designed dietary interventions are needed to confirm these findings and define specific dietary recommendations.
Sections du résumé
BACKGROUND
The Mediterranean diet has been associated with lower risk of breast cancer (BC) but evidence from prospective studies on the role of Mediterranean diet on BC survival remains sparse and conflicting. We aimed to investigate whether adherence to Mediterranean diet prior to diagnosis is associated with overall and BC-specific mortality.
METHODS
A total of 13,270 incident breast cancer cases were identified from an initial sample of 318,686 women in 9 countries from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Adherence to Mediterranean diet was estimated through the adapted relative Mediterranean diet (arMED), a 16-point score that includes 8 key components of the Mediterranean diet and excludes alcohol. The degree of adherence to arMED was classified as low (score 0-5), medium (score 6-8), and high (score 9-16). Multivariable Cox proportional hazards models were used to analyze the association between the arMED score and overall mortality, and Fine-Gray competing risks models were applied for BC-specific mortality.
RESULTS
After a mean follow-up of 8.6 years from diagnosis, 2340 women died, including 1475 from breast cancer. Among all BC survivors, low compared to medium adherence to arMED score was associated with a 13% higher risk of all-cause mortality (HR 1.13, 95%CI 1.01-1.26). High compared to medium adherence to arMED showed a non-statistically significant association (HR 0.94; 95% CI 0.84-1.05). With no statistically significant departures from linearity, on a continuous scale, a 3-unit increase in the arMED score was associated with an 8% reduced risk of overall mortality (HR
CONCLUSIONS
Consuming a Mediterranean diet before BC diagnosis may improve long-term prognosis, particularly after menopause and in cases of metastatic breast cancer. Well-designed dietary interventions are needed to confirm these findings and define specific dietary recommendations.
Identifiants
pubmed: 37365585
doi: 10.1186/s12916-023-02934-3
pii: 10.1186/s12916-023-02934-3
pmc: PMC10294413
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
225Subventions
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A29017
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Int J Cancer. 2023 Feb 15;152(4):635-644
pubmed: 36279885
Nutrients. 2018 Jan 10;10(1):
pubmed: 29320413
Eur J Clin Nutr. 2018 Jan;72(1):30-43
pubmed: 28488692
Nutrients. 2019 Oct 23;11(11):
pubmed: 31652816
Bone Marrow Transplant. 2020 Mar;55(3):538-543
pubmed: 31101889
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
CA Cancer J Clin. 2022 May;72(3):230-262
pubmed: 35294043
J Nutr. 2017 Jun;147(6):1174-1182
pubmed: 28424256
Cancer. 2020 Apr 1;126(7):1559-1567
pubmed: 31840240
Am J Clin Nutr. 2020 Dec 10;112(6):1492-1503
pubmed: 33022701
Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):678-686
pubmed: 36857773
Eur J Epidemiol. 2023 May;38(5):545-557
pubmed: 36988840
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
Nat Rev Clin Oncol. 2021 Oct;18(10):663-672
pubmed: 34079102
Nutrients. 2022 Jan 21;14(3):
pubmed: 35276833
Eur J Epidemiol. 2021 Sep;36(9):953-964
pubmed: 34148186
Int J Cancer. 2013 Jun 15;132(12):2918-27
pubmed: 23180513
Ann Oncol. 2012 Mar;23(3):604-610
pubmed: 21586686
Nutr Cancer. 2011;63(3):381-8
pubmed: 21462090
JNCI Cancer Spectr. 2021 Mar 02;5(2):
pubmed: 33928215
N Engl J Med. 2018 Jun 21;378(25):e34
pubmed: 29897866
Nutrients. 2022 Jan 14;14(2):
pubmed: 35057525
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Int J Epidemiol. 1997;26 Suppl 1:S6-14
pubmed: 9126529
Eur J Nutr. 2018 Sep;57(6):2133-2145
pubmed: 28634625
Br J Cancer. 2023 Mar;128(7):1301-1310
pubmed: 36737658
Int J Cancer. 2023 Feb 15;152(4):616-634
pubmed: 36279902